English | Español

Biospace
Patient Daily | Apr 16, 2026

Revolution Medicines reports pancreatic cancer drug doubles survival in late-stage trial
Patient Daily | Apr 16, 2026

Allogene reports early success for cell therapy in lymphoma trial interim analysis
Patient Daily | Apr 16, 2026

BioNTech and DualityBio report mid-stage trial results for endometrial cancer treatment
Patient Daily | Apr 16, 2026

FDA shows flexibility in rare disease drug trials amid evolving regulations
Patient Daily | Apr 16, 2026

Biopharma layoffs slow in early 2026 but job market remains uncertain
Patient Daily | Apr 16, 2026

BioSpace leaders discuss Q1 2026 job market trends and outlook
Patient Daily | Apr 16, 2026

Eli Lilly acquires CrossBridge Bio in $300 million deal for cancer drug development
Patient Daily | Apr 16, 2026

FDA urges over 2,200 drug developers to publish clinical trial results

Trending
Patient Daily | Jun 5, 2026

National Breathe Free donates $175,000 to support shelter for Tampa Bay families
+ Regulatory
A. D. Alderman | Jun 3, 2026

New study says TikTok content may normalize illicit vaping among youth as Trump Administration ramps up enforcement
+ Marketing
A. K. Abreu | Jun 9, 2026

Patient in 5.0 Google review: Gulf Coast Breathe Free Sinus & Allergy Centers ‘changed my life’
+ Regulatory
Patient Daily News Service | Jun 9, 2026

New colon cancer blood test wins Medicare coverage, but trails stool-based screening in detecting precancerous lesions